State Board of Administration of Florida Retirement System’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-11,187
Closed -$41.5K 2125
2025
Q2
$41.5K Hold
11,187
﹤0.01% 2127
2025
Q1
$36.1K Hold
11,187
﹤0.01% 2129
2024
Q4
$62.3K Hold
11,187
﹤0.01% 2153
2024
Q3
$121K Hold
11,187
﹤0.01% 2101
2024
Q2
$235K Buy
+11,187
New +$281K ﹤0.01% 1878
2024
Q1
Sell
-11,187
Closed -$227K 2254
2023
Q4
$227K Hold
11,187
﹤0.01% 2030
2023
Q3
$142K Buy
+11,187
New +$187K ﹤0.01% 2144

Other funds holding FDMT

State Board of Administration of Florida Retirement System's FDMT Position: Q3 2025 in Review

State Board of Administration of Florida Retirement System sold out of 4D Molecular Therapeutics (FDMT) in Q3 2025, closing a stake of 11,187 shares — an estimated $41.5K sold.

State Board of Administration of Florida Retirement System first reported a position in FDMT in Q3 2023 and held it in 7 quarters. The position peaked at $235K in Q2 2024. 134 funds tracked by Wall St. Rank hold FDMT as of Q3 2025.

  • State Board of Administration of Florida Retirement System reported no remaining 4D Molecular Therapeutics position as of Q3 2025 after selling out during the quarter.
  • State Board of Administration of Florida Retirement System sold 11,187 4D Molecular Therapeutics shares in Q3 2025, an estimated $41.5K.
  • State Board of Administration of Florida Retirement System first reported a position in 4D Molecular Therapeutics in Q3 2023 and held it in 7 quarters.
  • State Board of Administration of Florida Retirement System's 4D Molecular Therapeutics position peaked at $235K in Q2 2024.
  • 134 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q3 2025.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q3 2025, filed 14 Nov 2025.